Yamada, Motohiko
Tazawa, Hiroshi
Suemori, Kanto
Okada, Naohiro
Kajiwara, Yoshinori
Shoji, Ryohei
Nagai, Yasuo
Inoue, Hiroaki
Hashimoto, Naoyuki
Kanaya, Nobuhiko
Kikuchi, Satoru
Kuroda, Shinji
Michiue, Hiroyuki
Urata, Yasuo
Kagawa, Shunsuke
Fujiwara, Toshiyoshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP23K19511, JP21K07219, JP19H03731)
Japan Agency for Medical Research and Development (20ck0106569h0001)
Article History
Received: 27 January 2025
Accepted: 7 July 2025
First Online: 19 July 2025
Competing interests
: Y.U. is the President & CEO of Oncolys BioPharma, Inc. H.T. and T.F. are consultants of Oncolys BioPharma, Inc. The other authors have no potential conflicts of interest to disclose.